Risks of Pausing Medication Meds like semaglutide and tirzepatide are designed to help manage conditions like type 2 diabetes and obesity
While there is limited evidence that semaglutide specifically reduces laxative effectiveness, patients should be aware that individual responses may vary
The products pen label, accompanying patient information and carton were also identified as counterfeit
However, maintaining those results requires a proactive, multi-layered strategy to prevent weight regain
Additionally, there are no regulations for the control of therapeutic drugs based on exosomes that consider safety, effectiveness, and quality control, highlighting the urgent need for standardized methods and principles to manage these molecules
Research published in a 2025 narrative review found that GLP-1 medications can lead to muscle loss, micronutrient deficiencies, and digestive disruptions if nutritional needs aren't actively managed